Furthermore, genetic susceptibility was indicated in ALL and multiple myeloma, with constitutional mutations in genes such as IKZF1, SH2B3, PAX5 (ALL) and KDM1A/LSD1 (multiple myeloma). This evidence concerns the gene SH2B3 and plasma cell myeloma.